CoChat

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, Joseph, Toft, Michelle, Hickman, Suzanne E, Means, Terry K, Terada, Kinya, Geula, Changiz, Luster, Andrew D · 2007 · Nature Medicine

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Microglia are the principal immune cells of the brain. In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques. However, the role of microglia in Alzheimer disease has not been resolved. Microglia may be neuroprotective by phagocytosing amyloid-beta (Abeta), but their activation and the secretion of neurotoxins may also cause neurodegeneration. Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation. Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576). Alzheimer disease mice deficient in Ccr2 accumulated Abeta earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Abeta clearance and increased mortality. Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Abeta clearance.

Overview

Integrity signals

Registry

Crossref · 10.1038/nm1555

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

13 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 52 references

Cited by

Items 801–900 of 940

Metadata

Authors
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D.
Affiliations
  • Okayama University (JP)
  • Northwestern University (US)
Corresponding author
Luster, Andrew D
Venue
Nature Medicine
Published
2007-03-11
Volume
13
Issue
4
Pages
432-438
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2097867538
Cited by
915
References
51
Citations by year
2026: 29 · 2025: 27 · 2024: 41 · 2023: 35 · 2022: 44 · 2021: 70 · 2020: 51 · 2019: 37 · 2018: 42 · 2017: 51 · 2016: 51 · 2015: 60 · 2014: 43 · 2013: 53 · 2012: 70
FWCI
34.66
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Health Assistance Foundation
  • Dana Foundation
  • Gladstone Institutes
  • National Institutes of Health
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
CCR2, chemokine receptors, microglia, Alzheimer's disease, amyloid-beta clearance, Tg2576 mice, disease progression, neuroinflammation, gene dosage, neuroprotection
MeSH terms
Alzheimer Disease, Analysis of Variance, Animals, Brain, Crosses, Genetic, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry, Monocytes, Amyloid beta-Peptides, Microglia, Mice, Knockout, Models, Immunological, Chemokines, Mice, Receptors, CCR2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.